The Patent Finder
US

Modified 2' and 3'-Nucleoside Prodrugs for Treating Flaviviridae Infections

US 7,608,600 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Sep 30, 2028 · Medium confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Jun 27, 2003 as application 10/608,907 · Granted Oct 27, 2009
Base term plus 1922 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2003 2028
Clock starts
Jun 27, 2003
Ends no later than
Sep 30, 2028
Granted
Oct 27, 2009
base term patent term adjustment fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,922
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
52
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 1922 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 27, 2003, when this application, 10/608,907, was filedJun 27, 2023High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+1922 days, USPTO patent term adjustment recordSep 30, 2028High confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Sep 30, 2028Medium confidence

This family

US 6,596,700Lapsed on the fee record
Jul 2011
Jul 2011
US 6,566,344Term ended
Aug 2019
Aug 2019
US 6,569,837Term ended
no later than Oct 2020
no later than Oct 2020
US 6,787,526Lapsed on the fee record
Sep 2012
Sep 2012
US 6,946,450Term ended
Aug 2019
Aug 2019
US 7,608,600this patent
no later than Sep 2028
no later than Sep 2028
US 7,662,798Lapsed on the fee record
Feb 2022
Feb 2022
Application 11/005,440Abandoned
not computed
not computed
8 of 52 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Dec 23, 2008
Reel 22021, frame 541
Lacolla, PaoloIdenix Pharmaceuticals, Inc.Assignment of Assignor's Interest
May 6, 2009
Reel 22644, frame 923
Idenix Pharmaceuticals, Inc.; Idenix SARL; Idenix (Cayman) Limited; Universita Degli Studi Di Cagliari; Centre National Del la Recherche Scientifique; L'Universite Montpellier IIIdenix Pharmaceuticals, Inc.; University of Cagliari; The Centre National Del la Recherche Scientificque; L'Universite Montpellier IIAssignment of Assignor's Interest
May 6, 2009
reel/frame not recorded
Centre National Del la Recherche Scientifique; Idenix (Cayman) Limited; Idenix Pharmaceuticals, Inc.; Idenix SARL; L'Universite Montpellier II; Universita Degli Studi Di CagliariIdenix Pharmaceuticals, Inc.Assignment of Assignor's Interest
May 6, 2009
reel/frame not recorded
Centre National Del la Recherche Scientifique; Idenix (Cayman) Limited; Idenix Pharmaceuticals, Inc.; Idenix SARL; L'Universite Montpellier II; Universita Degli Studi Di CagliariUniversity of CagliariAssignment of Assignor's Interest
May 6, 2009
reel/frame not recorded
Centre National Del la Recherche Scientifique; Idenix (Cayman) Limited; Idenix Pharmaceuticals, Inc.; Idenix SARL; L'Universite Montpellier II; Universita Degli Studi Di CagliariThe Centre National Del la Recherche ScientificqueAssignment of Assignor's Interest
May 6, 2009
reel/frame not recorded
Centre National Del la Recherche Scientifique; Idenix (Cayman) Limited; Idenix Pharmaceuticals, Inc.; Idenix SARL; L'Universite Montpellier II; Universita Degli Studi Di CagliariL'Universite Montpellier IIAssignment of Assignor's Interest
Jan 27, 2016
Reel 37622, frame 842
Idenix Pharmaceuticals, Inc.Idenix Pharmaceuticals LLCChange of Name
Jan 27, 2016
Reel 37629, frame 73
L'Universite Montpellier IIL'Universite de MontpellierChange of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited